Compounds > almotriptan
Page last updated: 2024-09-03

almotriptan and caffeine

almotriptan has been researched along with caffeine in 7 studies

Compound Research Comparison

Studies
(almotriptan)		Trials
(almotriptan)		Recent Studies (post-2010)
(almotriptan)		Studies
(caffeine)		Trials
(caffeine)		Recent Studies (post-2010) (caffeine)
188594225,5012,3936,825

Protein Interaction Comparison

ProteinTaxonomyalmotriptan (IC50)caffeine (IC50)
AcetylcholinesteraseHomo sapiens (human)7.25

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Galván, J; Heras, J; Láinez, MJ; Vila, C1
Comas, A; Heras, J; Láinez, JM; Slof, J1

Reviews

1 review(s) available for almotriptan and caffeine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for almotriptan and caffeine

ArticleYear
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
    European journal of neurology, 2007, Volume: 14, Issue:3

    Topics: Acute Disease; Adult; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Migraine Disorders; Nausea; Patient Satisfaction; Phosphodiesterase Inhibitors; Photophobia; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents

2007

Other Studies

5 other study(ies) available for almotriptan and caffeine

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
[Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].
    Neurologia (Barcelona, Spain), 2009, Volume: 24, Issue:3

    Topics: Analgesics, Non-Narcotic; Caffeine; Cost-Benefit Analysis; Costs and Cost Analysis; Ergotamine; Health Care Costs; Humans; Migraine Disorders; Patient Satisfaction; Quality of Life; Treatment Outcome; Tryptamines

2009